BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4
133 results:

  • 1. Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report.
    Yang Y; Lee J; Woo CG; Lee OJ; Son SM
    Diagn Pathol; 2024 Jan; 19(1):16. PubMed ID: 38243242
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. SNHG15 promotes gallbladder cancer progression by enhancing the autophagy of tumor cell under nutrition stress.
    Min H; Yang L; Xu X; Geng Y; Liu F; Liu Y
    Cell Cycle; 2023 Oct; 22(19):2130-2141. PubMed ID: 37937948
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The relationship between the use of nucleos(t)ide analogs and metabolic parameters in patients with chronic hepatitis B.
    Yakut A; Aladag M
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9315-9323. PubMed ID: 37843345
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.
    Cowzer D; White JB; Chou JF; Chen PJ; Kim TH; Khalil DN; El Dika IH; Columna K; Yaqubie A; Light JS; Shia J; Yarmohammadi H; Erinjeri JP; Wei AC; Jarnagin W; Do RKG; Solit DB; Capanu M; Shah RH; Berger MF; Abou-Alfa GK; Harding JJ
    JCO Precis Oncol; 2023 Sep; 7():e2300272. PubMed ID: 37769223
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. tsc2 inactivation, low mutation burden and high macrophage infiltration characterise hepatic angiomyolipomas.
    Giannikou K; Klonowska K; Tsuji J; Wu S; Zhu Z; Probst CK; Kao KZ; Wu CL; Rodig S; Marino-Enriquez A; Zen Y; Schaefer IM; Kwiatkowski DJ
    Histopathology; 2023 Oct; 83(4):569-581. PubMed ID: 37679051
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab.
    Limousin W; Laurent-Puig P; Ziol M; Ganne-Carrié N; Nahon P; Ait-Omar A; Seror O; Sidali S; Campani C; Blanc P; Lermine A; Marisa L; Zucman-Rossi J; Nault JC
    J Hepatol; 2023 Dec; 79(6):1450-1458. PubMed ID: 37647991
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
    Navale P; Chatterjee D; Itani M; Trikalinos NA
    Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tuberous sclerosis associated lymphangioleiomyomatosis: A case report.
    Mushir A; Akhtar S; Hussain M
    J Pak Med Assoc; 2023 Apr; 73(4):908-911. PubMed ID: 37052013
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner.
    Kam CS; Ho DW; Ming VS; Tian L; Sze KM; Zhang VX; Tsui YM; Husain A; Lee JM; Wong CC; Chan AC; Cheung TT; Chan LK; Ng IO
    Cell Mol Gastroenterol Hepatol; 2023; 15(6):1325-1350. PubMed ID: 36806581
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. GCHA-Net: Global context and hybrid attention network for automatic liver segmentation.
    Liu H; Fu Y; Zhang S; Liu J; Wang Y; Wang G; Fang J
    Comput Biol Med; 2023 Jan; 152():106352. PubMed ID: 36481761
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents.
    Torrens L; Puigvehí M; Torres-Martín M; Wang H; Maeda M; Haber PK; Leonel T; García-López M; Esteban-Fabró R; Leow WQ; Montironi C; Torrecilla S; Varadarajan AR; Taik P; Campreciós G; Enkhbold C; Taivanbaatar E; Yerbolat A; Villanueva A; Pérez-Del-Pulgar S; Thung S; Chinburen J; Letouzé E; Zucman-Rossi J; Uzilov A; Neely J; Forns X; Roayaie S; Sia D; Llovet JM
    Clin Cancer Res; 2022 Oct; 28(20):4509-4520. PubMed ID: 35998012
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Integrated Analysis Highlights the Immunosuppressive Role of TREM2
    Zhou L; Wang M; Guo H; Hou J; Zhang Y; Li M; Wu X; Chen X; Wang L
    Front Immunol; 2022; 13():848367. PubMed ID: 35359989
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complex.
    Ritter DM; Fessler BK; Ebrahimi-Fakhari D; Wei J; Franz DN; Krueger DA; Trout AT; Towbin AJ
    Orphanet J Rare Dis; 2022 Mar; 17(1):124. PubMed ID: 35292049
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand.
    Dilokthornsakul P; Sawangjit R; Tangkijvanich P; Chayanupatkul M; Tanwandee T; Sukeepaisarnjaroen W; Sriuttha P; Permsuwan U
    Appl Health Econ Health Policy; 2022 Jul; 20(4):587-596. PubMed ID: 35141850
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mechanistic Target of Rapamycin (mTOR) Inhibitors.
    Wang D; Eisen HJ
    Handb Exp Pharmacol; 2022; 272():53-72. PubMed ID: 35091825
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Health benefits and phenolic compounds of Moringa oleifera leaves: A comprehensive review.
    Hassan MA; Xu T; Tian Y; Zhong Y; Ali FAZ; Yang X; Lu B
    Phytomedicine; 2021 Dec; 93():153771. PubMed ID: 34700271
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Targeted Next-Generation Sequencing Combined With Circulating-Free DNA Deciphers Spatial Heterogeneity of Resected Multifocal Hepatocellular Carcinoma.
    Lin J; Zhao S; Wang D; Song Y; Che Y; Yang X; Mao J; Xie F; Long J; Bai Y; Yang X; Zhang L; Bian J; Lu X; Sang X; Pan J; Wang K; Zhao H
    Front Immunol; 2021; 12():673248. PubMed ID: 34211467
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma.
    Wang X; Xing Z; Xu H; Yang H; Xing T
    Aging (Albany NY); 2021 Apr; 13(10):13822-13845. PubMed ID: 33929972
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria.
    Ye Q; Ling S; Jiang G; Shan Q; Xu S; Zhan Q; Wu Y; Liu Y; Zheng S; Xu X
    Eur J Surg Oncol; 2021 Oct; 47(10):2533-2542. PubMed ID: 33902956
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Everolimus treatment in a 3-month-old infant with tuberous sclerosis complex cardiac rhabdomyoma, severe left ventricular outflow tract obstruction, and hearing loss.
    Çetin M; Aydın AA; Karaman K
    Cardiol Young; 2021 Aug; 31(8):1359-1362. PubMed ID: 33658088
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.